The page is the record's research on the issuer — no analyst, no rating, no view. # Cabaletta Bio, Inc. (NASDAQ: CABA) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Cabaletta Bio, Inc., listed on NASDAQ under ticker CABA, ISIN US12674W1099; its LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Its security type is Corporate, its segment is not on the record, its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 66 filings across 31 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 5.5 days. The latest filing is dated 2026-11-06, two days before the record date, and is a regulatory filing. Exchange peers on NASDAQ (4,359 issuers) have a median cadence gap of 6.0 days, a median of 52 filings and a median latency of 5.0 days. Sector peers (176 issuers) have a median cadence gap of 5.5 days, a median of 65.5 filings and a median latency of 4.0 days. The issuer's filings by type are 24 regulatory filings, 19 directors' dealings, 10 results, 7 corporate news, 5 AGM/EGM and 1 prospectus. ## Auditor The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none). The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted. ## Orderability The outcome is not determinable: the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's investor-relations page names 10 research houses: Cantor Fitzgerald, Citi, Evercore ISI, Guggenheim, H.C. Wainwright, Jefferies, Morgan Stanley, TD Cowen, Wells Fargo and William Blair. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001759138.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/CABA (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.cabalettabio.com/investors/analyst-coverage (coverage) - https://mcp.us-cm-kg.ai/record/NASDAQ/CABA (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CABA · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp